Advertisement
Research Article| Volume 16, ISSUE 1, P125-137, March 1996

Download started.

Ok

Molecular Approaches for the Diagnosis of 21-Hydroxylase Deficiency and Congenital Adrenal Hyperplasia

  • Anna Wedell
    Correspondence
    Address reprint requests to: Anna Wedell, MD, PhD, Department of Molecular Medicine, Rolf Luft Center for Diabetes Research, Karolinska Hospital, S-171 76 Stockholm, Sweden
    Affiliations
    From the Department of Molecular Medicine, Rolf Luft Center for Diabetes Research, Karolinska Hospital, Stockholm, Sweden
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Congenital adrenal hyperplasia due to 21-hydroxylase deficiency results in deficiency of cortisol and aldosterone and overproduction of androgens. The 21-hydroxylase locus has a complicated structure, with a highly homologous pseudogene (CYP21P) and an active gene (CYP21) in tandem repeats, a high degree of interindividual variation in gene copy numbers, and exchange of sequences between CYP21P and CYP21. Nine mutations, representing sequences that are normally present in the pseudogene, account for about 95% of all affected CYP21 alleles. Accurate and rapid diagnostic evaluation of congenital adrenal hyperplasia due to 21-hydroxylase deficiency can be performed by typing directly for disease-causing mutations using allele-specific polymerase chain reaction (PCR). A strong correlation exists between genotype and phenotype; mutational analysis can be used to predict disease severity in affected individuals.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Amor M.
        • Parker K.L.
        • Globerman H.
        • et al.
        Mutation in the CYP21B gene (Ile-172→Asn) causes steroid 21-hydroxylase deficiency.
        Proc Natl Acad Sci USA. 1988; 85: 1600-1604
        • Carroll M.C.
        • Campbell R.D.
        • Porter R.R.
        Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.
        Proc Natl Acad Sci USA. 1985; 82: 521-525
        • Chiou S-H
        • Hu M-C
        • Chung B-C
        A missense mutation at Ilel72→Asn or Arg356→Trp causes steroid 21-hydroxylase deficiency.
        J Biol Chem. 1990; 265: 3549-3552
        • Collier S.
        • Sinnott P.J.
        • Dyer P.A.
        • et al.
        Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency haplotypes.
        EMBO J. 1989; 8: 1393-1402
        • David M.
        • Forest M.G.
        Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
        J Pediatr. 1984; 105: 799-803
        • Dupont B.
        • Oberfield S.E.
        • Smithwick E.M.
        • et al.
        Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency).
        Lancet. 1977; 2: 1309-1312
        • Forest M.G.
        • Betuel H.
        • David M.
        Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Update 88 of the French Multicentric Study.
        Endocrinol Res. 1989; 15: 277-301
        • Globerman H.
        • Amor M.
        • Parker K.L.
        • et al.
        Nonsense mutation causing steroid 21-hydroxylase deficiency.
        J Clin Invest. 1988; 82: 139-144
        • Haglund-Stengler B.
        • Ritzén E.M.
        • Gustafsson J.
        • et al.
        Haplotypes of the 21-hydroxylase gene region encoding mild 21-hydroxylase deficiency.
        Proc Natl Acad Sci USA. 1991; 88: 8352-8356
        • Helmberg A.
        • Tusie-Luna M-T
        • Tabarelli M.
        • et al.
        R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.
        Mol Endocrinol. 1992; 6: 1318-1322
        • Higashi Y.
        • Yoshioka H.
        • Yamane M.
        • et al.
        Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene.
        Proc Natl Acad Sci USA. 1986; 83: 2841-2845
        • Higashi Y.
        • Tanae A.
        • Inoue H.
        • et al.
        Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: Possible gene conversion products.
        Proc Natl Acad Sci USA. 1988; 85: 7486-7490
        • Loeuille G.A.
        • David M.
        • Forest M.G.
        Prenatal treatment of congenital adrenal hyperplasia: Report of a new case.
        Eur J Pediatr. 1990; 49: 237-240
        • Miller W.L.
        • Levine L.S.
        Molecular and clinical advances in congenital adrenal hyperplasia.
        J Pediatr. 1987; 111: 1-17
        • Miller W.L.
        Molecular biology of steroid hormone synthesis.
        Endocr Rev. 1988; 9: 295-318
        • Miller W.L.
        • Morel Y.
        The molecular genetics of 21-hydroxylase deficiency.
        Annu Rev Genet. 1989; 23: 371-393
        • Morel Y.
        • André J.
        • Uring-Lambert B.
        • et al.
        Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia.
        J Clin Invest. 1989; 83: 527-536
        • Morel Y.
        • Murena M.
        • Nicolino M.
        • et al.
        Correlation between genetic lesions of the CYP21B gene and the clinical forms of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: Report of a large study of 355 CAH chromosomes.
        Horm Res. 1992; 37: 13
        • Mornet E.
        • Crété P.
        • Kuttenn F.
        • et al.
        Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.
        Am J Hum Genet. 1991; 48: 79-88
        • New M.I.
        Clinical and endocrinological aspects of 21-hydroxylase deficiency.
        Ann NY Acad Sci. 1985; 458: 1-27
        • New M.I.
        Prenatal diagnosis and treatment of adrenogenital syndrome (steroid 21-hydroxylase deficiency).
        Dev Pharm Ther. 1990; 15: 200-210
        • Owerbach D.
        • Ballard A-L
        • Draznin M.B.
        Salt-wasting congenital adrenal hyperplasia: Detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
        J Clin Endocrinol Metab. 1992; 74: 553-558
        • Pang S.
        • Hotchkiss J.
        • Drash A.
        • et al.
        Microfilter paper method for 17-hydroxyprogester-one radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia.
        J Clin Endocrinol Metab. 1977; 45: 1003-1008
        • Pang S.
        • Pollack M.S.
        • Marshall R.N.
        • et al.
        Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
        N Engl J Med. 1990; 322: 111-115
        • Pang S.
        • Clark A.
        Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder.
        Screening. 1993; 2: 105-139
        • Partanen J.
        • Kere J.
        • Wessberg S.
        • et al.
        Determination of deletion sizes in the MHC-linked complement C4 and steroid 21-hydroxylase genes by pulsed-field gel electrophoresis.
        Genomics. 1989; 5: 345-349
        • Rodrigues N.R.
        • Dunham I.
        • Yung Yu C.
        • et al.
        Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia.
        EMBO J. 1987; 6: 1653-1661
        • Rumsby G.
        • Carroll M.C.
        • Porter R.R.
        • et al.
        Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia.
        J Med Genet. 1986; 23: 204-209
        • Schneider P.M.
        • Carroll M.C.
        • Alper C.A.
        • et al.
        Polymorphism of the human complement C4 and steroid 21-hydroxylase genes.
        J Clin Invest. 1986; 78: 650-657
        • Sinnott P.J.
        • Livieri C.
        • Sampietro M.
        • et al.
        CYP21/C4 gene organisation in Italian 21-hydroxylase deficiency families.
        Hum Genet. 1992; 88: 545-551
        • Speiser P.W.
        • Dupont B.
        • Rubinstein P.
        • et al.
        High frequency of nonclassical steroid 21-hydroxylase deficiency.
        Am J Hum Genet. 1985; 37: 650-667
        • Speiser P.W.
        • New M.I.
        • White P.C.
        Molecular genetic analysis of nonclassical steroid 21-hydroxylase deficiency associated with HLA-B14.DR1.
        N Engl J Med. 1988; 319: 19-23
        • Speiser P.W.
        • Laforgia N.
        • Whorwood C.
        • et al.
        First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency).
        J Clin Endocrinol Metab. 1990; 70: 838-848
        • Speiser P.W.
        • New M.I.
        • Tannin G.M.
        • et al.
        Genotype of Yupik eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
        Hum Genet. 1992; 88: 647-648
        • Tusie-Luna M-T
        • Speiser P.W.
        • Dumic M.
        • et al.
        A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.
        Mol Endocrinol. 1991; 5: 685-692
        • Wedell A.
        • Ritzén M.E.
        • Haglund-Stengler B.
        • et al.
        Steroid 21-hydroxylase deficiency: Three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.
        Proc Natl Acad Sci USA. 1992; 89: 7232-7236
        • Wedell A.
        • Luthman H.
        Steroid 21-hydroxylase (P450c21): A new allele and spread of mutations through the pseudogene.
        Hum Genet. 1993; 91: 236-240
        • Wedell A.
        • Luthman H.
        Steroid 21-hydroxylase deficiency: Two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations.
        Hum Mol Genet. 1993; 2: 499-504
        • Wedell A.
        • Stengler B.
        • Luthman H.
        Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency.
        Hum Genet. 1994; 94: 50-54
        • Wedell A.
        • Thilén A.
        • Ritzén E.M.
        • et al.
        Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation.
        J Clin Endocrinol Metab. 1994; 78: 1145-1152
        • Wedell A.
        • Xu C.
        • Luthman H.
        A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the Swedish population.
        Hum Genet. 1994; 93: 204-206
        • Werkmeister J.W.
        • New M.I.
        • Dupont B.
        • et al.
        Frequent deletion and duplication of the steroid 21-hydroxylase genes.
        Am J Hum Genet. 1986; 39: 461-469
        • White P.C.
        • Grossberger D.
        • Onufer B.J.
        • et al.
        Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man.
        Proc Natl Acad Sci USA. 1985; 82: 1089-1093
        • White P.C.
        • New M.I.
        • Dupont B.
        Structure of human steroid 21-hydroxylase genes.
        Proc Natl Acad Sci USA. 1986; 83: 5111-5115
        • White P.C.
        • New M.I.
        • Dupont B.
        Congenital adrenal hyperplasia.
        N Engl J Med. 1987; 316: 1519-1524